Study finds certain MS therapies may not slow disability progression Dr. Kamal Kant Kohli22 Oct 2024 9:45 PM ISTIn people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before disability worsened...
Roche gets USFDA nod for Ocrevus Zunovo for relapsing and progressive multiple sclerosis Ruchika Sharma19 Sept 2024 4:00 PM ISTBasel: Roche announced that the United States Food and Drug Administration (U.S. FDA) has approved OCREVUS ZUNOVO (ocrelizumab &...
MS drugs taken while breastfeeding may not affect child development, finds new research Dr. Kamal Kant Kohli14 March 2024 9:00 PM ISTCertain medications for multiple sclerosis (MS) called monoclonal antibodies, taken while breastfeeding, may not affect the development of a child...
Roche Pharma unveils multiple sclerosis treatment drug Ocrevus in India Ruchika Sharma29 Feb 2024 5:00 PM ISTNew Delhi: Roche Pharma India has launched a drug for the treatment of Multiple Sclerosis (MS), expanding its neurology portfolio to cater...
Modify Clinical Study Protocol: CDSCO Panel Tells Roche On Multiple Sclerosis Drug Ocrelizumab Dr. Divya Colin11 Feb 2024 6:00 PM ISTNew Delhi: In response to the proposal presented by drug major Roche to conduct the Phase IV clinical trial for the drug product Ocrelizumab 300 mg...
Roche announces positive phase III results for Ocrevus twice a year, 10-minute subcutaneous injection in multiple sclerosis patients Ruchika Sharma16 July 2023 2:30 PM ISTBasel: Roche has announced that the Phase III OCARINA II trial evaluating OCREVUS (ocrelizumab) as a twice a year 10-minute subcutaneous injection met...
Roche gets CDCSO panel nod to market multiple sclerosis drug Ocrelizumab Dr. Divya Colin26 Jan 2023 6:00 PM ISTNew Delhi: Pharmaceutical major, Roche has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Control...
US FDA, EMA accepted applications for OCREVUS (ocrelizumab) shorter 2-hour infusion time: Roche Ruchika Sharma22 April 2020 1:25 PM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License Application...
Seven drugs with $1 billion sale potential reaching market in 2016 savita thakur thakur5 Feb 2016 8:00 AM ISTLondon: Drug companies are likely to launch seven "blockbuster" drugs in 2016, each with $1 billion-plus annual sales potential, led by new treatments...
